Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Loo

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Brain Stimulation|October 23, 2010
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label studyPhilip G Janicak, Ziad Nahas, Sarah H Lisanby, et al.
The Journal of ECT|July 5, 2024
A Randomized Controlled Trial of Ultrabrief Right Unilateral ECT With Frontoparietal Versus Temporoparietal Electrode Placement for Severe Depression-The RAFT ECT TrialColleen Loo, Ana Rita Barreiros, Donel Martin, et al.
Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.
Brain Stimulation|July 24, 2017
Response to letter to the editor: Safety of transcranial direct current stimulation: Evidence based update 2016Marom Bikson, Pnina Grossman, Adantchede Louis Zannou, et al.
The American Journal of Psychiatry|March 11, 2026
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive DisorderJordy J E Rovers, Philip F P van Eijndhoven, Christopher Abbot, et al.
Brain Stimulation|February 6, 2018
Rigor and reproducibility in research with transcranial electrical stimulation: An NIMH-sponsored workshopMarom Bikson, Andre R Brunoni, Leigh E Charvet, et al.
Journal of Affective Disorders|December 2, 2019
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority studyFernanda S Correia-Melo, Gustavo C Leal, Flávia Vieira, et al.
Brain Stimulation|July 4, 2016
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016Marom Bikson, Pnina Grossman, Chris Thomas, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 21, 2020
Intravenous arketamine for treatment-resistant depression: open-label pilot studyGustavo C Leal, Igor D Bandeira, Fernanda S Correia-Melo, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Brain Stimulation|October 23, 2010
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label studyPhilip G Janicak, Ziad Nahas, Sarah H Lisanby, et al.
The Journal of ECT|July 5, 2024
A Randomized Controlled Trial of Ultrabrief Right Unilateral ECT With Frontoparietal Versus Temporoparietal Electrode Placement for Severe Depression-The RAFT ECT TrialColleen Loo, Ana Rita Barreiros, Donel Martin, et al.
Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.
Brain Stimulation|July 24, 2017
Response to letter to the editor: Safety of transcranial direct current stimulation: Evidence based update 2016Marom Bikson, Pnina Grossman, Adantchede Louis Zannou, et al.
The American Journal of Psychiatry|March 11, 2026
A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive DisorderJordy J E Rovers, Philip F P van Eijndhoven, Christopher Abbot, et al.
Brain Stimulation|February 6, 2018
Rigor and reproducibility in research with transcranial electrical stimulation: An NIMH-sponsored workshopMarom Bikson, Andre R Brunoni, Leigh E Charvet, et al.
Journal of Affective Disorders|December 2, 2019
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority studyFernanda S Correia-Melo, Gustavo C Leal, Flávia Vieira, et al.
Brain Stimulation|July 4, 2016
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016Marom Bikson, Pnina Grossman, Chris Thomas, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 21, 2020
Intravenous arketamine for treatment-resistant depression: open-label pilot studyGustavo C Leal, Igor D Bandeira, Fernanda S Correia-Melo, et al.
Pageof 15